Literature DB >> 12523769

Continuous monitoring for Cryptosporidium--a novel approach to public health protection.

A Lloyd1, D Drury.   

Abstract

Regulations requiring water utilities in England and Wales to carry out continuous monitoring for Cryptosporidium in treated water were introduced in June 1999. The rationale of the Regulations and the technical basis for the sampling and analysis are reviewed. The results of the first nine months of monitoring are summarised and compared with other equivalent data sets. The impact of the Regulations on water utilities operational practices and the implications for public health protection are discussed.

Mesh:

Substances:

Year:  2002        PMID: 12523769

Source DB:  PubMed          Journal:  Water Sci Technol        ISSN: 0273-1223            Impact factor:   1.915


  5 in total

1.  Detection of Cryptosporidium oocysts in water: effect of the number of samples and analytic replicates on test results.

Authors:  Lihua Xiao; Kerri A Alderisio; Jianlin Jiang
Journal:  Appl Environ Microbiol       Date:  2006-09       Impact factor: 4.792

Review 2.  A hundred-year retrospective on cryptosporidiosis.

Authors:  Saul Tzipori; Giovanni Widmer
Journal:  Trends Parasitol       Date:  2008-03-07

3.  Cryptosporidium source tracking in the Potomac River watershed.

Authors:  Wenli Yang; Plato Chen; Eric N Villegas; Ronald B Landy; Charles Kanetsky; Vitaliano Cama; Theresa Dearen; Cherie L Schultz; Kenneth G Orndorff; Gregory J Prelewicz; Miranda H Brown; Kim Roy Young; Lihua Xiao
Journal:  Appl Environ Microbiol       Date:  2008-09-05       Impact factor: 4.792

4.  Cryptosporidiosis decline after regulation, England and Wales, 1989-2005.

Authors:  Iain R Lake; Gordon Nichols; Graham Bentham; Florence C D Harrison; Paul R Hunter; Sari R Kovats
Journal:  Emerg Infect Dis       Date:  2007-04       Impact factor: 6.883

5.  Case-control study of environmental and social factors influencing cryptosporidiosis.

Authors:  Iain R Lake; Florence C D Harrison; Rachel M Chalmers; Graham Bentham; Gordon Nichols; Paul R Hunter; R Sari Kovats; Chris Grundy
Journal:  Eur J Epidemiol       Date:  2007-09-21       Impact factor: 8.082

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.